Clinical Trial Update: TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of transarterial chemoembolization with recombinant human adenovirus for hepatocellular carcinoma; current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Recombinant Human Adenovirus (Adenovirus vector)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN